Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

36.87
-0.9100-2.41%
Post-market: 36.890.0200+0.05%19:59 EDT
Volume:2.50M
Turnover:92.77M
Market Cap:4.35B
PE:13.33
High:38.52
Open:37.68
Low:36.70
Close:37.78
52wk High:42.81
52wk Low:22.22
Shares:118.00M
Float Shares:109.00M
Volume Ratio:1.35
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-20.92
PE(LYR):22.48

Loading ...

Indivior PLC Earnings Call: Merger, Margins and Growth

TIPRANKS
·
Yesterday

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Top Indivior Executive Makes Bold New Stock Move

TIPRANKS
·
Aug 06

Indivior Chief Accounting Officer Woodrow D Anderson Acquires 1,500 Shares Worth $54,420

Reuters
·
Aug 06

Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs

Reuters
·
Aug 06

Indivior price target lowered to $43 from $46 at Barclays

TIPRANKS
·
Aug 05

Barclays Reaffirms Their Buy Rating on Indivior (INDV)

TIPRANKS
·
Aug 05

Cumberland Pharmaceuticals Q2 Loss Widens After Apotex Transaction

Reuters
·
Aug 05

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Indivior price target raised to $53 from $50 at Craig-Hallum

TIPRANKS
·
Aug 04

Indivior Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion

Reuters
·
Aug 04

Crinetics Q2 Revenue Jumps on Palsonify Launch, Withdraws Guidance

Reuters
·
Aug 04

Germany's Fresenius Medical Q2 Revenue Beats; 2026 Outlook Reaffirmed

Reuters
·
Aug 04

U.S. Stocks on the MOVE -Visa, Bowhead Specialty, Micron

Reuters
·
Aug 03

Indivior and Supernus announce tax-free merger of equals

TIPRANKS
·
Aug 03

Supernus, Indivior Merge to Strengthen Neuroscience Drug Portfolio

Reuters
·
Aug 03

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Reuters
·
Aug 03

Indivior Announces Merger Agreement to Acquire Supernus

TIPRANKS
·
Aug 03

Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger

MT Newswires Live
·
Aug 03